牙髓治疗材料生物相容性研究方法与实验模型的批判性分析
本文综述牙髓治疗材料生物相容性评价的概念、结构化测试程序和国际标准,详述现有测试方法的优势与局限。生物相容性评价分四阶段:全身毒性、局部组织刺激、临床前测试和临床评价。新材料使用前必须证明安全无害,但研究者常因标准获取受限、指南局限和方法复杂而未能遵循国际标准。
要点
- 生物相容性评价分四阶段:全身毒性、局部组织刺激、临床前测试和临床评价。
- 评价结果取决于测试材料及测试方法,需理解各筛选试验的优势与局限以准确解读结果。
- 新材料临床使用前必须证明安全无害,但研究者常因标准获取受限等原因未遵循国际标准。
核心结论
- 生物相容性评价需采用结构化的四阶段测试程序,理解各筛选试验的优势与局限对准确解读结果至关重要。
- 新材料临床使用前必须证明安全无害,但研究者常因标准获取受限、指南局限和新实验方法复杂而未能遵循国际标准,可能导致技术错误。
- 许多实验室已建立各自的生物相容性测试策略,使研究结果间的比较更加困难。
研究设计与样本
- 本文为综述,讨论牙髓治疗材料生物相容性的概念、结构化测试程序和国际标准,并详述现有测试方法及其优势与局限。
主要发现
- 生物相容性评价由四阶段组成:全身毒性、局部组织刺激、临床前测试和临床评价。
- 牙髓治疗材料与组织直接接触,适应证从活髓治疗到根管充填材料及牙髓外科用材料。
- 纳米材料、基因治疗和组织工程生物材料等新技术可能给患者带来新的危害。
- 现有牙科材料安全性评价国际标准包括ISO 10993系列、ISO 7405和ISO 14155-1。
关键数值与推荐
- 生物相容性结构化评价包括四个阶段:全身毒性、局部组织刺激、临床前测试和临床评价。
- 牙科材料安全性评价的国际标准为ISO 10993系列、ISO 7405和ISO 14155-1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究者常因无法获取标准、指南的局限性及新实验方法的复杂性而未能遵循现有国际标准,可能导致技术错误。
- 许多实验室已建立各自的生物相容性测试策略,使不同研究结果之间的比较更加困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Materials used for endodontics and with direct contact to tissues have a wide range of indications, from vital pulpal treatments to root filling materials and those used in endodontic surgery. In principle, interaction with dental materials may result in damage to tissues locally or systemically. Thus, a great variety of test methods are applied to evaluate a materials' potential risk of adverse biological effects to ensure their biocompatibility before commercialization. However, the results of biocompatibility evaluations are dependent on not only the tested materials but also the test methods due to the diversity of these effects and numerous variables involved. In addition, diverse biological effects require equally diverse assessments on a structured and planned approach. Such a structured assessment of the materials consists of four phases: general toxicity, local tissue irritation, pre-clinical tests and clinical evaluations. Various types of screening assays are available; it is imperative to understand their advantages and limitations to recognize their appropriateness and for an accurate interpretation of their results. Recent scientific advances are rapidly introducing new materials to endodontics including nanomaterials, gene therapy and tissue engineering biomaterials. These new modalities open a new era to restore and regenerate dental tissues; however, all these new technologies can also present new hazards to patients. Before any clinical usage, new materials must be proven to be safe and not hazardous to health. Certain international standards exist for safety evaluation of dental materials (ISO 10993 series, ISO 7405 and ISO 14155-1), but researchers often fail to follow these standards due to lack of access to standards, limitation of the guidelines and complexity of new experimental methods, which may cause technical errors. Moreover, many laboratories have developed their testing strategy for biocompatibility, which makes any comparison between findings more difficult. The purpose of this review was to discuss the concept of biocompatibility, structured test programmes and international standards for testing the biocompatibility of endodontic material biocompatibility. The text will further detail current test methods for evaluating the biocompatibility of endodontic materials, and their advantages and limitations.
引用
- Hosseinpour S, Gaudin A, Peters OA, et al. A critical analysis of research methods and experimental models to study biocompatibility of endodontic materials. Int Endod J. 2022. PMID: 35124840. doi:10.1111/iej.13701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。